Navigating Uncertainty: Characterizing Rebound Lactic Acidosis in Pediatric Normothermic Machine Perfusion
Authors:
- Chun‐Sing HuangCHChun‐Sing Huang
- Alonzo NeedumANAlonzo Needum
- Sarah G. Van WinkleSWSarah G. Van Winkle
- Gwendolyn B. HenryGHGwendolyn B. Henry
- Rayhan Neil JhanjiRJRayhan Neil Jhanji
- Emma HillsEHEmma Hills
- Naseem RavanbakhshNRNaseem Ravanbakhsh
- Abbas RanaARAbbas Rana
- Kyle SoltysKSKyle Soltys
- George MazariegosGMGeorge Mazariegos
- N. Thao N. GalvánNGN. Thao N. Galván
- John GossJGJohn Goss
Open Access
- 13 October 2026
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70500
Abstract
Background: Normothermic machine perfusion (NMP) is an emerging strategy for pediatric liver transplantation, but pediatric‐specific viability criteria remain undefined. Lactate clearance, extrapolated from adult protocols, is a central marker of allograft function. In our pediatric NMP (pNMP) experience, we observed a novel pattern: initial clearance followed by secondary rise, termed rebound lactic acidosis. Methods: We retrospectively reviewed pediatric liver allografts preserved on the TransMedics Organ Care System at two centers (January 2025 through June 2026). After excluding donors > 35 kg, 18 perfusions (17 transplants) were classified as rebound lactic acidosis (lactate rise > 0.5 mmol/L after initial clearance) or sustained clearance. Rebound cases were characterized by lactate kinetics, perfusion parameters, acid–base status, bile production, histology, and recipient outcomes. Results: Six allografts demonstrated rebound, with onset 1.0–6.6 h into perfusion. All sustained bile production throughout perfusion. Circuit alkalosis temporally correlated with rebound in three cases and improved with gas flow reduction. The first allograft was discarded; the remaining five were transplanted, including one perfused for 35.5 h. Recipients had elevated POD1 transaminases and INR that normalized by POD7; three are discharged home and two remain hospitalized, all with functioning allografts (follow‐up up to 312 days). Conclusions: Rebound lactic acidosis during pNMP may not indicate allograft nonviability and may be ameliorated by modifying circuit perfusion or pH. Lactate kinetics should be interpreted within a multiparametric viability framework incorporating perfusion adequacy, acid–base status, bile production, liver function, and histology. Pediatric‐specific criteria are needed to safely expand the donor pool.Keywords
This publication has 12 references indexed in Scilit:
- Normothermic machine perfusion of pediatric liver allografts: A single-center case seriesAmerican Journal of Transplantation, 2026
- Evaluation of Liver Maximum Capacity Measurements to Monitor Hepatocellular Function During Extended Normothermic Machine PerfusionTransplantation, 2025
- The Role of Machine Perfusion for Liver Transplantation in ChildrenPediatric Transplantation, 2025
- Split Liver Transplantation Using Machine Perfusion in Pediatric RecipientsAmerican Journal of Transplantation, 2025
- Dynamic Lactate Clearance Patterns During Normothermic Machine Perfusion Predict Posttransplant Biliary Complications in Donation After Circulatory Death Liver TransplantationTransplantation Direct, 2025
- Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver TransplantJAMA Surgery, 2022
- Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 HoursLiver Transplantation, 2021
- Transplantation of discarded livers following viability testing with normothermic machine perfusionNature Communications, 2020
- Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High‐Risk Livers Using Normothermic Machine PerfusionLiver Transplantation, 2018
- Primary non‐function is frequently associated with fatty liver allografts and high mortality after re‐transplantationLiver International, 2017